0001474064-13-000044.txt : 20130219 0001474064-13-000044.hdr.sgml : 20130219 20130215162746 ACCESSION NUMBER: 0001474064-13-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130213 FILED AS OF DATE: 20130215 DATE AS OF CHANGE: 20130215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARCEAU ROGER CENTRAL INDEX KEY: 0001451767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 13620041 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-02-13 0000890465 NPS PHARMACEUTICALS INC NPSP 0001451767 GARCEAU ROGER 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP & CMO Employee Stock Options (right to buy) 8.23 2013-02-13 4 A 0 84941 0 A 2023-02-13 Common Stock 84941 84941 D Restricted Stock Units 2013-02-13 4 A 0 31592 0 A Common Stock 31592 31592 D Stock options granted under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan (the "Plan"). The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 6.25% every three months thereafter. Each restricted stock unit was awarded under the Plan and represents a contingent right to receive one share of the Issuer's common stock. Restricted Stock Units awarded under the Plan will vest as follows: (i) one third will vest on the first anniversary of date of grant, one third on the second anniversary of date of grant, and one third on the third anniversary of date of grant. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the Restricted Stock Units. /s/ Roger Garceau, by Edward Stratemeier as attorney-in-fact 2013-02-15